Arimidex

How Does Arimidex (Anastrozole) Work?

Anastrozole works by selectively blocking the aromatase enzyme (CYP19A1), which is responsible for converting androgens (androstenedione and testosterone) into estrogen (estrone and estradiol) in peripheral tissues such as fat, muscle, liver, and breast tissue. In postmenopausal women, this peripheral conversion is the primary source of circulating estrogen.

By blocking aromatase, anastrozole dramatically reduces estrogen levels throughout the body. At the standard 1 mg daily dose, serum estradiol is reduced by approximately

70% within 24 hours and approximately

80% after 14 days of daily dosing, bringing estradiol to the lower limit of detection (below 3.7 pmol/L). Since hormone receptor-positive breast cancer cells rely on estrogen for growth signaling, this estrogen deprivation effectively slows or stops tumor growth and reduces the risk of cancer recurrence after surgery.

Anastrozole does not directly kill cancer cells like chemotherapy. Instead, it removes the hormonal fuel that drives their growth — a strategy that requires sustained daily dosing for up to 5 to 10 years in the adjuvant setting. It has no meaningful effect on adrenal corticosteroid production (cortisol, aldosterone), making it well-tolerated from an adrenal perspective.

How Hard Is It to Find Arimidex (Anastrozole) in Stock?

As of 2026, anastrozole is not on the FDA's official drug shortage list and is generally widely available from multiple generic manufacturers. The expiration of AstraZeneca's patent around 2010-2012 opened the market to numerous generic producers, providing meaningful supply chain redundancy. This makes anastrozole considerably more stable in supply than many other specialty drugs.

That said, individual pharmacies may experience localized inventory gaps due to distributor issues, pharmacy-level ordering patterns, or formulary requirements that specify one manufacturer's version. A brief manufacturing hiccup at one supplier in early 2025 caused a roughly 12% temporary price and supply impact nationally — illustrating that even stable drugs can have episodic disruptions. Patients in rural areas or those using specialty pharmacies may encounter more frequent availability challenges.

If your pharmacy is out of anastrozole, calling multiple pharmacies in your area or using medfinder — which calls pharmacies near you to find which ones have it in stock — is the fastest approach to resolving a refill gap.

Who Can Prescribe Arimidex (Anastrozole)?

Anastrozole is not a controlled substance and has no DEA scheduling. Any licensed physician, nurse practitioner, or physician assistant in the United States can legally prescribe it. There are no DEA-specific prescribing restrictions, refill limitations, or mandatory in-person visit requirements related to controlled substance status.

In clinical practice, anastrozole is most commonly prescribed by:

• Medical Oncologists — primary prescribers for breast cancer treatment; initiate, monitor, and adjust anastrozole therapy
• Breast Surgeons / Surgical Oncologists — often initiate adjuvant hormonal therapy after breast cancer surgery
• Gynecologic Oncologists — manage hormone-related aspects of breast cancer in postmenopausal women
• Primary Care Physicians (PCPs) — for patients stable on long-term adjuvant therapy, PCPs often take over prescribing for routine refills and monitoring (bone density, cholesterol)
• Nurse Practitioners and Physician Assistants — NPs and PAs in oncology practices routinely prescribe and manage anastrozole therapy

Telehealth oncology and primary care providers can prescribe and refill anastrozole without the federal restrictions applicable to controlled substances. For established patients on long-term adjuvant therapy, telehealth follow-up for prescription refills and side effect monitoring is widely available and appropriate.

Is Arimidex (Anastrozole) a Controlled Substance?

No. Anastrozole (Arimidex) is not a controlled substance and is not scheduled by the DEA. It is a prescription-only medication, but there are no federal prescribing restrictions, refill limits, or mandatory in-person visit requirements that apply specifically because of its DEA status.

Prescribers do not need a DEA number to prescribe anastrozole, and patients do not need to visit their prescriber in person solely for this medication (though follow-up oncology visits are clinically important for monitoring bone density, cholesterol, and treatment response). Telehealth providers can prescribe and refill anastrozole without the additional hurdles that apply to controlled substances.

Because anastrozole is not scheduled, pharmacies can dispense it to any patient with a valid prescription from a licensed prescriber, and the prescription can be transmitted electronically, by phone, or by paper without any controlled substance-specific requirements.

Common Side Effects of Arimidex (Anastrozole)

Most side effects of anastrozole are related to its estrogen-lowering mechanism and are similar to menopause symptoms, often more pronounced:

• Joint pain and stiffness (arthralgia) — affects up to 35% of patients
• Hot flashes and night sweats
• Fatigue and weakness
• Vaginal dryness and discomfort
• Nausea, headache
• Peripheral edema (swelling in hands/feet)
• Elevated LDL cholesterol
• Carpal tunnel syndrome (numbness/tingling in hands)

Serious side effects requiring immediate medical attention:

• Bone loss (osteopenia/osteoporosis) and fractures — monitor with periodic DXA scans
• Ischemic cardiovascular events — increased risk in patients with pre-existing heart disease (17% on ATAC trial)
• Liver toxicity (hepatotoxicity) — rare; watch for jaundice, dark urine, right upper abdominal pain
• Severe allergic reactions (anaphylaxis, angioedema) — less than 1 in 10,000 patients; seek emergency care immediately
• Severe skin reactions (Stevens-Johnson syndrome, erythema multiforme) — stop drug and contact physician immediately
• Tendon disorders (tendon rupture, tendonitis) — report sudden tendon pain or weakness immediately

Final Thoughts on Arimidex (Anastrozole)

Anastrozole (Arimidex) is one of the most effective and well-tolerated breast cancer medications available, with over two decades of clinical evidence supporting its use. For postmenopausal women with hormone receptor-positive breast cancer, it represents a cornerstone of adjuvant therapy and is often taken for 5 to 10 years to reduce recurrence risk.

The medication's affordability as a generic is a genuine advantage. With pharmacy discount programs like GoodRx and SingleCare, most patients can access anastrozole for $5-$13 per month — remarkable for a cancer medication. The key challenges are managing side effects (particularly joint pain and bone loss) and ensuring consistent prescription access, especially for patients in areas with limited pharmacy options.

If you're having trouble filling your anastrozole prescription, remember that inventory varies significantly from pharmacy to pharmacy. Before skipping a dose or switching medications, try searching other pharmacies in your area. medfinder calls pharmacies near you to find which ones have your medication in stock, saving you time and helping ensure you stay on track with your treatment.